Muscle Tension, Laparoscopy
Conditions
Interventions
This will be a single-blind randomized clinical trial. The number of patients included will be 60. The patient will be admitted to the Surgical Center of the Agudos Block and will be approached by the
B=bolus administration). He will also prepare the rocuronium infusion or bolus dose according to the group. The team's anesthesiologist will initiate denitrogenation with 100% oxygen, as usual, and wi
Sponsors
Hospital Central do Exército
Hospital Central do Exército
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Adults over 18 years old; both sexes; ASA I, II and III - Anesthetic risk classification according to the American Society of Anesthesiologists [ASA1 (patient without comorbidities), ASA 2 ( patient with compensated comorbidities, without functional limitations), ASA 3 (patient with decompensated comorbidities with mild functional limitation.)]; surgery expected to last more than 1 hour
Exclusion criteria
Exclusion criteria: Known allergy to Rocuronium and/or Sugammadex; prior extensive surgery in the surgery cavity; locomotor or neurological disease; gestation; kidney or liver failure; refusal by the patient or his guardian; concomitant use of drugs that are known to interact with Rocuronium according to the manufacturer's package leaflet
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the total dose of rocuronium used to maintain deep muscle relaxation in intermittent bolus and continuous infusion techniques in laparoscopic surgeries | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes are not expected | — |
Countries
Brazil
Contacts
Public ContactDayse Rodrigues
Hospital Central do Exército
Outcome results
None listed